Literature DB >> 16755378

Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

F Tribl1, K Marcus, H E Meyer, G Bringmann, M Gerlach, P Riederer.   

Abstract

The powerful combination of subcellular fractionation and protein identification by electrospray ionization tandem mass spectrometry (ESI-MS/MS) pioneered the molecular elucidation of neuromelanin (NM) granules. We recently isolated NM granules from the human brain and succeeded in the establishment of the first protein profile of this compartment. NM granules are pigmented organelles, which are mainly found in the catecholaminergic neurons of the human substantia nigra (SN) pars compacta and the locus coeruleus. These granules contain the insoluble pigment NM, which is regarded as the most important iron storage system in these neurons. A global examination of NM granules, however, has so far been hampered due to the lack of a pigmented brain stem in rodents, the absence of an appropriate experimental system and their scarcity in the human brain. 'Subcellular proteomics', which increasingly emerges as the method of choice to characterize cellular compartments and to elucidate their biogenesis, has recently been shown to be an adequate approach to tackle a thorough description of NM granules. Thereby, NM granules could be described as a 'lysosome-related organelle'. This indicates a genetic program underlying a biogenesis of NM rather than its autoxidative formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755378     DOI: 10.1007/s00702-006-0452-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  40 in total

Review 1.  Proteomics meets cell biology: the establishment of subcellular proteomes.

Authors:  E Jung; M Heller; J C Sanchez; D F Hochstrasser
Journal:  Electrophoresis       Date:  2000-10       Impact factor: 3.535

2.  A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Cell Proteomics       Date:  2004-12-02       Impact factor: 5.911

3.  "Subcellular proteomics" of neuromelanin granules isolated from the human brain.

Authors:  Florian Tribl; Manfred Gerlach; Katrin Marcus; Esther Asan; Thomas Tatschner; Thomas Arzberger; Helmut E Meyer; Gerhard Bringmann; Peter Riederer
Journal:  Mol Cell Proteomics       Date:  2005-04-25       Impact factor: 5.911

4.  Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Authors:  Glenda M Halliday; Anita Ophof; Melissa Broe; Poul H Jensen; Emma Kettle; Heidi Fedorow; Michael I Cartwright; Francine M Griffiths; Claire E Shepherd; Kay L Double
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

5.  Increased nigral iron content in postmortem parkinsonian brain.

Authors:  D T Dexter; F R Wells; F Agid; Y Agid; A J Lees; P Jenner; C D Marsden
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

6.  Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals.

Authors:  J Klose
Journal:  Humangenetik       Date:  1975

7.  A model for melanosome biogenesis based on the purification and analysis of early melanosomes.

Authors:  T Kushimoto; V Basrur; J Valencia; J Matsunaga; W D Vieira; V J Ferrans; J Muller; E Appella; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

8.  Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.

Authors:  K L Double; L Zecca; P Costi; M Mauer; C Griesinger; S Ito; D Ben-Shachar; G Bringmann; R G Fariello; P Riederer; M Gerlach
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

9.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

10.  Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Authors:  A Kastner; E C Hirsch; O Lejeune; F Javoy-Agid; O Rascol; Y Agid
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

View more
  15 in total

Review 1.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

2.  Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.

Authors:  Florian Tribl; Esther Asan; Thomas Arzberger; Thomas Tatschner; Elmar Langenfeld; Helmut E Meyer; Gerhard Bringmann; Peter Riederer; Manfred Gerlach; Katrin Marcus
Journal:  Mol Cell Proteomics       Date:  2009-03-24       Impact factor: 5.911

Review 3.  Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics.

Authors:  Marjan Huizing; Amanda Helip-Wooley; Wendy Westbroek; Meral Gunay-Aygun; William A Gahl
Journal:  Annu Rev Genomics Hum Genet       Date:  2008       Impact factor: 8.929

Review 4.  The biogenesis of lysosomes and lysosome-related organelles.

Authors:  J Paul Luzio; Yvonne Hackmann; Nele M G Dieckmann; Gillian M Griffiths
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

Review 5.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

Review 6.  Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.

Authors:  W Michael Caudle; Theo K Bammler; Yvonne Lin; Sheng Pan; Jing Zhang
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

Review 7.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 8.  Tyrosinase-expressing neuronal cell line as in vitro model of Parkinson's disease.

Authors:  Takafumi Hasegawa
Journal:  Int J Mol Sci       Date:  2010-03-12       Impact factor: 5.923

9.  Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.

Authors:  Sarah Plum; Simone Steinbach; Johannes Attems; Sharon Keers; Peter Riederer; Manfred Gerlach; Caroline May; Katrin Marcus
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

10.  Cerebrospinal fluid biomarker candidates for parkinsonian disorders.

Authors:  Radu Constantinescu; Stefania Mondello
Journal:  Front Neurol       Date:  2013-01-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.